{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:02:04Z","timestamp":1792551724376,"version":"4.5.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Histochemistry and Cytochemistry"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.proghi.2013.07.001","type":"journal-article","created":{"date-parts":[[2013,7,26]],"date-time":"2013-07-26T00:16:05Z","timestamp":1374797765000},"page":"65-98","source":"Crossref","is-referenced-by-count":47,"title":["Vitamin D in thyroid tumorigenesis and development"],"prefix":"10.1016","volume":"48","author":[{"given":"Isabelle","family":"Clinckspoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieve","family":"Verlinden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Bouillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Verstuyf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Decallonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.proghi.2013.07.001_bib0005","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/1933719107304565","article-title":"Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers","volume":"14","author":"Agic","year":"2007","journal-title":"Reprod Sci"},{"key":"10.1016\/j.proghi.2013.07.001_bib0010","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1089\/thy.2000.10.587","article-title":"Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion, Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group","volume":"10","author":"Ain","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.proghi.2013.07.001_bib0015","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.bjc.6604544","article-title":"Induction of sodium iodide symporter gene and molecular characterisation of HNF3 beta\/FoxA2, TTF-1 and C\/EBP beta in thyroid carcinoma cells","volume":"99","author":"Akagi","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.proghi.2013.07.001_bib0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00280-005-0059-7","article-title":"Expression of VDR and CYP24A1 mRNA in human tumors","volume":"57","author":"Anderson","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0025","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1245\/ASO.2006.05.042","article-title":"Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches","volume":"13","author":"Are","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-642-55580-0_5","article-title":"Antiproliferative signalling by 1,25(OH)2D3 in prostate and breast cancer is suppressed by a mechanism involving histone deacetylation","volume":"164","author":"Banwell","year":"2003","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.proghi.2013.07.001_bib0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jsbmb.2006.12.054","article-title":"1,25-Dihydroxyvitamin D3\/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism","volume":"103","author":"Barthel","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0040","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1210\/en.2007-1655","article-title":"Active intestinal calcium transport in the absence of transient receptor potential vanilloid type 6 and calbindin-D9k","volume":"149","author":"Benn","year":"2008","journal-title":"Endocrinology."},{"key":"10.1016\/j.proghi.2013.07.001_bib0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0083-6729(05)71004-9","article-title":"Thyroid hormones and brain development","volume":"71","author":"Bernal","year":"2005","journal-title":"Vitam Horm"},{"key":"10.1016\/j.proghi.2013.07.001_bib0050","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/jc.2012-1520","article-title":"Mayo Phase 2 Consortium; Mayo Clinic Endocrine Malignances Disease Oriented Group. A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer","volume":"97","author":"Bible","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.proghi.2013.07.001_bib0055","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1369\/jhc.4B6271.2004","article-title":"25-hydroxyvitamin D3-1alpha-hydroxylase expression in normal and malignant human colon","volume":"52","author":"Bises","year":"2004","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.proghi.2013.07.001_bib0060","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1210\/en.2008-1437","article-title":"Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid","volume":"150","author":"Bizhanova","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.proghi.2013.07.001_bib0065","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1210\/en.2009-1272","article-title":"Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation","volume":"151","author":"Bjerre","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.proghi.2013.07.001_bib0070","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jsbmb.2010.03.069","article-title":"Expression of the vitamin D receptor, 25-hydroxylases, 1alpha-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer","volume":"121","author":"Blomberg","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/en.141.1.10","article-title":"Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2","volume":"141","author":"Blutt","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.proghi.2013.07.001_bib0080","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1210\/en.2008-0078","article-title":"Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells","volume":"149","author":"Borgogni","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.proghi.2013.07.001_bib0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jsbmb.2005.06.013","article-title":"Mechanisms for the selective action of Vitamin D analogs","volume":"97","author":"Bouillon","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0090","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jsbmb.2006.09.014","article-title":"Vitamin D and cancer","volume":"102","author":"Bouillon","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0095","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1210\/er.2008-0004","article-title":"Vitamin D and human health: lessons from vitamin D receptor null mice","volume":"29","author":"Bouillon","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.proghi.2013.07.001_bib0100","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2265.1985.tb01103.x","article-title":"Extra-endocrine functions of vitamin D","volume":"23","author":"Braidman","year":"1985","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0105","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1210\/jc.2011-1109","article-title":"Update on external beam radiation therapy in thyroid cancer","volume":"96","author":"Brierley","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.proghi.2013.07.001_bib0110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1515\/jpem-2012-0021","article-title":"Vitamin D status in children with Hashimoto thyroiditis","volume":"25","author":"Camurdan","year":"2012","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.proghi.2013.07.001_bib0115","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1073\/pnas.0402490101","article-title":"Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase","volume":"101","author":"Cheng","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.proghi.2013.07.001_bib0120","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.clon.2010.04.008","article-title":"Molecular targeted therapies for patients with refractory thyroid cancer","volume":"22","author":"Chougnet","year":"2010","journal-title":"Clin Oncol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2010.12.008","article-title":"1,25-dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer","volume":"124","author":"Clinckspoor","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0130","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1369\/0022155412447296","article-title":"Altered expression of key players of vitamin D metabolism and signaling in malignant and benign thyroid tumors","volume":"60","author":"Clinckspoor","year":"2012","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.proghi.2013.07.001_bib0135","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000342363","article-title":"The vitamin D receptor in thyroid development and function","volume":"1","author":"Clinckspoor","year":"2012","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.proghi.2013.07.001_bib0140","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2265.2004.02015.x","article-title":"Lack of association of the vitamin D receptor gene with Graves\u2019 disease in UK Caucasians","volume":"60","author":"Collins","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0145","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"19","author":"Cooper","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.proghi.2013.07.001_bib0150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ncpendmet1023","article-title":"Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls","volume":"5","author":"Costante","year":"2009","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.proghi.2013.07.001_bib0155","first-page":"2333","article-title":"Vitamin D receptor and cytokeratin expression may be progression indicators in human colon cancer","volume":"16","author":"Cross","year":"1996","journal-title":"Anticancer Res"},{"key":"10.1016\/j.proghi.2013.07.001_bib0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jsbmb.2005.06.005","article-title":"The Vitamin D endocrine system of the gut--its possible role in colorectal cancer prevention","volume":"97","author":"Cross","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0165","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1210\/en.2004-0785","article-title":"Vitamin D3 administration induces nuclear p27 accumulation, restores differentiation, and reduces tumor burden in a mouse model of metastatic follicular thyroid cancer","volume":"145","author":"Dackiw","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.proghi.2013.07.001_bib0170","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrc2196","article-title":"Vitamin D signalling pathways in cancer: potential for anticancer therapeutics","volume":"7","author":"Deeb","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.proghi.2013.07.001_bib0175","first-page":"2304","article-title":"Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy","volume":"60","author":"Diaz","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.proghi.2013.07.001_bib0180","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","volume":"289","author":"Dusso","year":"2005","journal-title":"Vitamin D. Am J Physiol Renal Physiol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0185","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1359\/jbmr.0301204","article-title":"The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes","volume":"19","author":"Eelen","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.proghi.2013.07.001_bib0190","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.2174\/092986707781058823","article-title":"Mechanism and potential of the growth-inhibitory actions of vitamin D and analogs","volume":"14","author":"Eelen","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.proghi.2013.07.001_bib0195","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.chembiol.2008.08.008","article-title":"Superagonistic fluorinated vitamin D3 analogs stabilize helix 12 of the vitamin D receptor","volume":"15","author":"Eelen","year":"2008","journal-title":"Chem Biol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0200","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jsbmb.2010.01.010","article-title":"CD-ring modified vitamin D3 analogs and their superagonistic action","volume":"121","author":"Eelen","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1530\/EJE-12-0048","article-title":"Vitamin D deficiency is not associated with early stages of thyroid autoimmunity","volume":"167","author":"Effraimidis","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0210","series-title":"Abstract presented at the 14th International Thyroid Congress (ITC)","article-title":"Vitamin D deficiency modulates the regulation of the pituitary-thyroid axis and thyroid gene expression","author":"Egrise","year":"2010"},{"key":"10.1016\/j.proghi.2013.07.001_bib0215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0090-1229(90)90005-B","article-title":"In vivo beneficial effects of cyclosporin A and 1,25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis","volume":"54","author":"Fournier","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0220","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1042\/bj2060181","article-title":"Specific binding of 1,25-dihydroxycholecalciferol in human medullary thyroid carcinoma","volume":"206","author":"Freake","year":"1982","journal-title":"Biochem J"},{"key":"10.1016\/j.proghi.2013.07.001_bib0225","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/jnci\/djm204","article-title":"Prospective study of serum vitamin D and cancer mortality in the United States","volume":"99","author":"Freedman","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.proghi.2013.07.001_bib0230","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/978-3-642-55580-0_17","article-title":"Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer","volume":"164","author":"Friedrich","year":"2003","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.proghi.2013.07.001_bib0235","first-page":"2615","article-title":"Analysis of 25-hydroxyvitamin D3-1alpha-hydroxylase in normal and malignant breast tissue","volume":"26","author":"Friedrich","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1016\/j.proghi.2013.07.001_bib0240","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/ijc.25439","article-title":"Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma","volume":"128","author":"Gandini","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.proghi.2013.07.001_bib0245","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1089\/thy.2012.0011","article-title":"Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature","volume":"22","author":"Giordano","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.proghi.2013.07.001_bib0250","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/jnci\/djj101","article-title":"Prospective study of predictors of vitamin D status and cancer incidence and mortality in men","volume":"98","author":"Giovannucci","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.proghi.2013.07.001_bib0255","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.amepre.2006.11.004","article-title":"Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis","volume":"32","author":"Gorham","year":"2007","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.proghi.2013.07.001_bib0260","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1017\/S0007114509220824","article-title":"Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based survey","volume":"102","author":"Goswami","year":"2009","journal-title":"Br J Nutr"},{"key":"10.1016\/j.proghi.2013.07.001_bib0265","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jcb.20182","article-title":"Vitamin D3 modulated gene expression patterns in human primary normal and cancer prostate cells","volume":"93","author":"Guzey","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.proghi.2013.07.001_bib0270","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1210\/jc.2010-2318","article-title":"GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide","volume":"96","author":"Hegedus","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.proghi.2013.07.001_bib0275","first-page":"1043","article-title":"(1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis","volume":"7","author":"Hershberger","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.proghi.2013.07.001_bib0280","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/thy.2009.0115","article-title":"Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma","volume":"20","author":"Higashiyama","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.proghi.2013.07.001_bib0285","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1172\/JCI200319826","article-title":"Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5","volume":"112","author":"Hoenderop","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.proghi.2013.07.001_bib0290","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1369\/jhc.2009.954339","article-title":"The candidate oncogene CYP24A1: A potential biomarker for colorectal tumorigenesis","volume":"58","author":"Horvath","year":"2010","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.proghi.2013.07.001_bib0295","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1210\/jc.2009-1888","article-title":"Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways","volume":"95","author":"Hou","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.proghi.2013.07.001_bib0300","first-page":"137","article-title":"Regulation of insulin-like growth factor (IGF) II and IGF binding protein 3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25(OH)2D3 and its analog EB1089","volume":"13","author":"Huynh","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0305","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/(SICI)1097-0215(19990531)81:5<730::AID-IJC11>3.0.CO;2-Q","article-title":"Inhibition of angiogenesis as a mechanism for inhibition by 1alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymethane in Wistar rats","volume":"81","author":"Iseki","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.proghi.2013.07.001_bib0310","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0960-0760(96)00048-9","article-title":"Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells","volume":"58","author":"James","year":"1996","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0315","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1089\/thy.2006.16.1229","article-title":"Outcomes of patients with differentiated thyroid carcinoma following initial therapy","volume":"16","author":"Jonklaas","year":"2006","journal-title":"Thyroid"},{"key":"10.1016\/j.proghi.2013.07.001_bib0320","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/annonc\/mdr117","article-title":"New treatment modalities in advanced thyroid cancer","volume":"23","author":"Kapiteijn","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0325","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/cncr.23223","article-title":"Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice","volume":"112","author":"Karmakar","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.proghi.2013.07.001_bib0330","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1200\/JCO.2005.14.167","article-title":"Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer","volume":"23","author":"Kelly","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0335","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1369\/jhc.5A6734.2005","article-title":"25-hydroxyvitamin D3 1alpha-hydroxylase and vitamin D receptor expression in papillary thyroid carcinoma","volume":"54","author":"Khadzkou","year":"2006","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.proghi.2013.07.001_bib0340","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2174\/092986707780362871","article-title":"The ERp57\/GRp58\/1,25D3-MARRS receptor: multiple functional roles in diverse cell systems","volume":"14","author":"Khanal","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.proghi.2013.07.001_bib0345","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1210\/jc.87.4.1814","article-title":"Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma","volume":"87","author":"Khoo","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.proghi.2013.07.001_bib0350","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/cmi.2010.73","article-title":"Vitamin D and autoimmune thyroid diseases","volume":"8","author":"Kivity","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0355","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/thy.2008.0403","article-title":"Medullary thyroid cancer: management guidelines of the American Thyroid Association","volume":"19","author":"Kloos","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.proghi.2013.07.001_bib0360","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrc1836","article-title":"Pathogenetic mechanisms in thyroid follicular-cell neoplasia","volume":"6","author":"Kondo","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.proghi.2013.07.001_bib0365","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1006123819675","article-title":"Combined effect of vitamin D3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo","volume":"53","author":"Koshizuka","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.proghi.2013.07.001_bib0370","first-page":"3511","article-title":"The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature","volume":"29","author":"Kostner","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.proghi.2013.07.001_bib0375","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0303-7207(91)90201-3","article-title":"Characterization of a 1,25-dihydroxy-vitamin D3 receptor in FRTL-5 cells, Evidence for an inhibitory effect of 1,25-dihydroxy-vitamin D3 on thyrotropin-induced iodide uptake","volume":"81","author":"Lamberg-Allardt","year":"1991","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0380","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1200\/JCO.2009.22.1291","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"27","author":"Lane","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0385","first-page":"805716","article-title":"The prevalence of vitamin D deficiency is similar between thyroid nodule and thyroid cancer patients","author":"Laney","year":"2010","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0390","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/ajcn\/85.6.1586","article-title":"Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial","volume":"85","author":"Lappe","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.proghi.2013.07.001_bib0395","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1210\/jcem-55-2-361","article-title":"Normal serum 1,25-dihydroxyvitamin D in patients with medullary carcinoma of the thyroid","volume":"55","author":"Lee","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.proghi.2013.07.001_bib0400","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.beem.2011.05.008","article-title":"Calcemic actions of vitamin D: Effects on the intestine, kidney and bone","volume":"25","author":"Lieben","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.proghi.2013.07.001_bib0405","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jcla.20110","article-title":"Vitamin D receptor gene polymorphisms are associated with risk of Hashimoto's thyroiditis in Chinese patients in Taiwan","volume":"20","author":"Lin","year":"2006","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.proghi.2013.07.001_bib0410","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1101\/gad.10.2.142","article-title":"Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937","volume":"10","author":"Liu","year":"1996","journal-title":"Genes Dev"},{"key":"10.1016\/j.proghi.2013.07.001_bib0415","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0002-9440(10)64870-5","article-title":"Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN\/akt-dependent and -independent pathways","volume":"160","author":"Liu","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0420","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1210\/me.2005-0117","article-title":"1alpha,25-Dihydroxyvitamin D3 targets PTEN-dependent fibronectin expression to restore thyroid cancer cell adhesiveness","volume":"19","author":"Liu","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0425","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.humpath.2006.04.029","article-title":"Expression of vitamin D3 receptor in kidney tumors","volume":"37","author":"Liu","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0430","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/1471-2407-10-483","article-title":"Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions","volume":"10","author":"Lopes","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.proghi.2013.07.001_bib0435","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1158\/1078-0432.CCR-06-0367","article-title":"Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo","volume":"12","author":"Luong","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.proghi.2013.07.001_bib0440","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1158\/1055-9965.EPI-07-0753","article-title":"Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk","volume":"16","author":"Lurie","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.proghi.2013.07.001_bib0445","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7150\/jca.1.101","article-title":"Vitamin D in combination cancer treatment","volume":"1","author":"Ma","year":"2010","journal-title":"J Cancer"},{"key":"10.1016\/j.proghi.2013.07.001_bib0450","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10875-007-9124-9","article-title":"Lack of association of VDR gene polymorphisms with thyroid autoimmune disorders: familial and case\/control studies","volume":"28","author":"Maalej","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0455","unstructured":"Mangelsdorf, TJ. 2005. Tissue-specific expression patterns of nuclear receptors. Available at www.nursa.org\/10.1621\/datasets.02001."},{"key":"10.1016\/j.proghi.2013.07.001_bib0460","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/01.RES.87.3.214","article-title":"1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo","volume":"87","author":"Mantell","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.proghi.2013.07.001_bib0465","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35106079","article-title":"Histone deacetylases and cancer: causes and therapies","volume":"1","author":"Marks","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.proghi.2013.07.001_bib0470","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nbt1272","article-title":"Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug","volume":"25","author":"Marks","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0475","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF03350323","article-title":"Chronic hypervitaminosis D3 determines a decrease in C-cell numbers and calcitonin levels in rats","volume":"21","author":"Martin-Lacave","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.proghi.2013.07.001_bib0480","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1158\/1055-9965.EPI-05-0257","article-title":"Expression of vitamin D receptor and 25-hydroxyvitamin D3-1{alpha}-hydroxylase in normal and malignant human colon","volume":"14","author":"Matusiak","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.proghi.2013.07.001_bib0485","first-page":"155","article-title":"Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase, and vitamin D receptor mRNA in normal and malignant breast tissue","volume":"29","author":"McCarthy","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.proghi.2013.07.001_bib0490","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1210\/en.2008-1191","article-title":"Vitamin D deficiency modulates Graves\u2019 hyperthyroidism induced in BALB\/c mice by thyrotropin receptor immunization","volume":"150","author":"Misharin","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.proghi.2013.07.001_bib0495","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1158\/1078-0432.CCR-03-0776","article-title":"Novel histone deacetylase inhibitors in the treatment of thyroid cancer","volume":"11","author":"Mitsiades","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.proghi.2013.07.001_bib0500","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/thy.2008.0321","article-title":"A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome","volume":"19","author":"Mooney","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.proghi.2013.07.001_bib0505","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1469-7580.2009.01095.x","article-title":"Functional expression of the thyrotropin receptor in C cells: new insights into their involvement in the hypothalamic-pituitary-thyroid axis","volume":"215","author":"Morillo-Bernal","year":"2009","journal-title":"J Anat"},{"key":"10.1016\/j.proghi.2013.07.001_bib0510","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1067\/mcp.2002.129305","article-title":"Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel","volume":"72","author":"Muindi","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.proghi.2013.07.001_bib0515","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1172\/JCI113305","article-title":"Regulation of calcitonin gene transcription by vitamin D metabolites in vivo in the rat","volume":"81","author":"Naveh-Many","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.proghi.2013.07.001_bib0520","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0006-291X(02)02482-8","article-title":"A specific binding protein\/receptor for 1alpha,25-dihydroxyvitamin D(3) is present in an intestinal caveolae membrane fraction","volume":"298","author":"Norman","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.proghi.2013.07.001_bib0525","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1507\/endocrj.46.243","article-title":"Effect of 22-oxa-1,25-dihydroxyvitamin D3 on human thyroid cancer cell growth","volume":"46","author":"Okano","year":"1999","journal-title":"Endocr J"},{"key":"10.1016\/j.proghi.2013.07.001_bib0530","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/eje.1.02158","article-title":"European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium","volume":"154","author":"Pacini","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0535","first-page":"7799","article-title":"Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells","volume":"63","author":"Palmer","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.proghi.2013.07.001_bib0540","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1530\/eje.0.1460777","article-title":"Vitamin D 1alpha-hydroxylase (CYP1alpha) polymorphism in Graves\u2019 disease, Hashimoto's thyroiditis and type 1 diabetes mellitus","volume":"146","author":"Pani","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0545","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.suc.2004.01.005","article-title":"Redifferentiation therapy for thyroid cancer","volume":"84","author":"Park","year":"2004","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.proghi.2013.07.001_bib0550","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1089\/thy.2008.0388","article-title":"Vitamin D receptor polymorphisms in differentiated thyroid carcinoma","volume":"19","author":"Penna-Martinez","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.proghi.2013.07.001_bib0555","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/thy.2011.0330","article-title":"Impaired vitamin D activation and association with CYP24A1 haplotypes in differentiated thyroid carcinoma","volume":"22","author":"Penna-Martinez","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.proghi.2013.07.001_bib0560","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1158\/1535-7163.MCT-09-0366","article-title":"Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance","volume":"8","author":"Perez","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.proghi.2013.07.001_bib0565","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/sj.onc.1204269","article-title":"Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A","volume":"20","author":"Rashid","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.proghi.2013.07.001_bib0570","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1681\/ASN.2005060632","article-title":"Hypervitaminosis D mediates compensatory Ca2+ hyperabsorption in TRPV5 knockout mice","volume":"16","author":"Renkema","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0575","first-page":"160","article-title":"Vitamin D deficiency as a potentially modifiable risk factor for thyroid cancer","volume":"41","author":"Roskies","year":"2012","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.proghi.2013.07.001_bib0580","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.surg.2006.07.027","article-title":"Patterns of expression of cell cycle\/apoptosis genes along the spectrum of thyroid carcinoma progression","volume":"140","author":"Saltman","year":"2006","journal-title":"Surgery"},{"key":"10.1016\/j.proghi.2013.07.001_bib0585","doi-asserted-by":"crossref","first-page":"R980","DOI":"10.1186\/bcr1332","article-title":"25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue","volume":"7","author":"Segersten","year":"2005","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.proghi.2013.07.001_bib0590","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1089\/thy.2010.0096","article-title":"Thyroid cancer resistance to vitamin D receptor activation is associated with 24-hydroxylase levels but not the ff FokI polymorphism","volume":"20","author":"Sharma","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.proghi.2013.07.001_bib0595","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0140-6736(03)12488-9","article-title":"Thyroid carcinoma","volume":"361","author":"Sherman","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.proghi.2013.07.001_bib0600","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.1073\/pnas.96.14.8253","article-title":"Calcitonin is a major regulator for the expression of renal 25-hydroxyvitamin D3-1alpha-hydroxylase gene in normocalcemic rats","volume":"96","author":"Shinki","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.proghi.2013.07.001_bib0605","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000084340","article-title":"Immunohistochemical expression of Bcl-2, Ki-67, and p21 in patients with papillary thyroid cancer","volume":"26","author":"Siironen","year":"2005","journal-title":"Tumour Biol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0610","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ygyno.2010.06.008","article-title":"Analysis of vitamin D receptor expression and clinical correlations in patients with ovarian cancer","volume":"119","author":"Silvagno","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0615","article-title":"Vitamin D less-calcemic analog modulates the expression of estrogen receptors, vitamin D receptor and 1\u03b1-hydroxylase 25-hydroxy vitamin D in human thyroid cancer cell lines","author":"Somjen","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0620","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1744-313X.2008.00748.x","article-title":"Association of vitamin D receptor gene 3\u2019-variants with Hashimoto's thyroiditis in the Croatian population","volume":"35","author":"Stefanic","year":"2008","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.proghi.2013.07.001_bib0625","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.arcmed.2010.04.004","article-title":"Decreased 1-25 dihydroxyvitamin D3 concentration in peripheral blood serum of patients with thyroid cancer","volume":"41","author":"Stepien","year":"2010","journal-title":"Arch Med Res"},{"key":"10.1016\/j.proghi.2013.07.001_bib0630","first-page":"611","article-title":"Antineoplastic activity of 1,25(OH)2D3 and its analogue 22-oxacalcitriol against human anaplastic thyroid carcinoma cell lines in vitro","volume":"4","author":"Suzuki","year":"1999","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.proghi.2013.07.001_bib0635","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/acta.0.1150225","article-title":"Systemic effects of 1,25-dihydroxyvitamin D3 on the pituitary-hypothalamic axis in rats","volume":"115","author":"T\u00f6rnquist","year":"1987","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.proghi.2013.07.001_bib0640","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/1541-7786.MCR-06-0318","article-title":"Increased expression of corepressors in aggressive androgen-independent prostate cancer cells results in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness","volume":"5","author":"Ting","year":"2007","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.proghi.2013.07.001_bib0645","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.canlet.2006.03.025","article-title":"Docetaxel-induced growth inhibition and apoptosis in androgen independent prostate cancer cells are enhanced by 1alpha,25-dihydroxyvitamin D3","volume":"247","author":"Ting","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.proghi.2013.07.001_bib0650","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1210\/endo-127-3-1419","article-title":"1,25-Dihydroxyvitamin D3 antagonizes interferon-gamma-induced expression of class II major histocompatibility antigens on thyroid follicular and testicular Leydig cells","volume":"127","author":"Tokuda","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.proghi.2013.07.001_bib0655","first-page":"77","article-title":"Cross HS; Mechanism of antimitogenic action of vitamin D in human colon carcinoma cells: relevance for suppression of epidermal growth factor-stimulated cell growth","volume":"11","author":"Tong","year":"1999","journal-title":"Oncol Res"},{"key":"10.1016\/j.proghi.2013.07.001_bib0660","doi-asserted-by":"crossref","first-page":"13324","DOI":"10.1073\/pnas.231474698","article-title":"Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects","volume":"98","author":"Van Cromphaut","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.proghi.2013.07.001_bib0665","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1111\/j.1753-4887.2008.00096.x","article-title":"Regulation of vitamin D homeostasis: implications for the immune system","volume":"66","author":"van Etten","year":"2008","journal-title":"Nutr Rev"},{"key":"10.1016\/j.proghi.2013.07.001_bib0670","doi-asserted-by":"crossref","first-page":"37319","DOI":"10.1074\/jbc.M503587200","article-title":"Characterization of the condensin component Cnap1 and protein kinase Melk as novel E2F target genes down-regulated by 1,25-dihydroxyvitamin D3","volume":"280","author":"Verlinden","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.proghi.2013.07.001_bib0675","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1210\/jc.86.7.3091","article-title":"Pseudohypoparathyroidism Ia and hypercalcitoninemia","volume":"86","author":"Vlaeminck-Guillem","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.proghi.2013.07.001_bib0680","first-page":"1021","article-title":"Vitamin D receptor expression is associated with colon cancer in ulcerative colitis","volume":"22","author":"Wada","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1016\/j.proghi.2013.07.001_bib0685","first-page":"2040","article-title":"1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death","volume":"60","author":"Wang","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.proghi.2013.07.001_bib0690","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1210\/en.140.4.1649","article-title":"1Alpha,25-dihydroxyvitamin D3 up-regulates Bcl-2 expression and protects normal human thyrocytes from programmed cell death","volume":"140","author":"Wang","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.proghi.2013.07.001_bib0695","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/1097-4644(20010315)80:4<471::AID-JCB1001>3.0.CO;2-J","article-title":"Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells","volume":"80","author":"Wang","year":"2001","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.proghi.2013.07.001_bib0700","series-title":"Werner & Ingbar's the thyroid a fundamental and clinical text","author":"Werner","year":"2005"},{"key":"10.1016\/j.proghi.2013.07.001_bib0705","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0021-9258(18)57335-X","article-title":"Plasma inorganic iodide as a homeostatic regulator of thyroid function","volume":"174","author":"Wolff","year":"1948","journal-title":"J Biol Chem"},{"key":"10.1016\/j.proghi.2013.07.001_bib0710","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1210\/jc.2008-1631","article-title":"Lack of therapeutic effect of the histone deacetylase inhibitor vorinostat in patients with metastatic radioiodine-refractory thyroid carcinoma","volume":"94","author":"Woyach","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.proghi.2013.07.001_bib0715","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/S0960-894X(02)00222-6","article-title":"Vitamin D(3): synthesis of seco-C-9,11-bisnor-17-methyl-1 alpha,25-dihydroxyvitamin D(3) analogues","volume":"12","author":"Wu","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.proghi.2013.07.001_bib0720","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.283.5406.1317","article-title":"Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators","volume":"283","author":"Yanagisawa","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.proghi.2013.07.001_bib0725","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1152\/physrev.2001.81.3.1097","article-title":"Physiological and molecular basis of TH action","volume":"81","author":"Yen","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.proghi.2013.07.001_bib0730","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2036.2009.04022.x","article-title":"Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk","volume":"30","author":"Yin","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.proghi.2013.07.001_bib0735","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S8756-3282(02)00688-9","article-title":"Forty years of calcitonin-where are we now?. A tribute to the work of Iain Macintyre","volume":"30","author":"Zaidi","year":"2002","journal-title":"FRS. Bone"},{"key":"10.1016\/j.proghi.2013.07.001_bib0740","doi-asserted-by":"crossref","first-page":"11059","DOI":"10.1074\/jbc.M806561200","article-title":"Calcitonin, a regulator of the 25-hydroxyvitamin D3 1alpha-hydroxylase gene","volume":"284","author":"Zhong","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.proghi.2013.07.001_bib0745","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1024\/0300-9831.77.3.236","article-title":"Interactions of vitamin A and iodine deficiencies: effects on the pituitary-thyroid axis","volume":"77","author":"Zimmermann","year":"2007","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.proghi.2013.07.001_bib0750","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jsbmb.2005.06.024","article-title":"Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues","volume":"97","author":"Zinser","year":"2005","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["Progress in Histochemistry and Cytochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079633613000120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079633613000120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T04:43:59Z","timestamp":1646196239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079633613000120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":150,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0079633613000120"],"URL":"https:\/\/doi.org\/10.1016\/j.proghi.2013.07.001","relation":{},"ISSN":["0079-6336"],"issn-type":[{"value":"0079-6336","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}